Next Article in Journal
Synthesis of Compounds of the Pyrimidine Series Based on the Reactions of 3-Arylmethylidenefuran-2(3H)-ones with N,N-Binucleophilic Reagents
Previous Article in Journal
Enhanced Uptake of Fe3O4 Nanoparticles by Intestinal Epithelial Cells in a State of Inflammation
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessArticle
Molecules 2017, 22(8), 1260; doi:10.3390/molecules22081260

Pharmacokinetic Study of Biotransformation Products from an Anxiolytic Fraction of Tilia americana

1
Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS), Argentina No. 1, CP 62790 Xochitepec, Morelos, Mexico
2
Doctorado en Farmacia, Facultad de Farmacia. Universidad Autónoma del Estado de Morelos, Av. Universidad No. 1001, CP 62209 Cuernavaca, Morelos, Mexico
*
Author to whom correspondence should be addressed.
Received: 16 June 2017 / Revised: 20 July 2017 / Accepted: 21 July 2017 / Published: 27 July 2017
View Full-Text   |   Download PDF [1398 KB, uploaded 27 July 2017]   |  

Abstract

An anxiolytic fraction of Tilia americana standardized in tiliroside, rutin, quercitrin, quercetin glucoside, and kaempferol was obtained. After oral administration of the fraction, the above-mentioned flavonoids were not detected in plasma over 24 h. However, meta and para hydroxyphenylacetic acid and dihydroxyphenylacetic acid (m-HPAA, p-HPAA and DOPAC) were monitored. These are the biotransformation compounds of the aglycones of kaempferol and quercetin; these aglycones are products of the other flavonoids present in the anxiolytic fraction. The analytical methods (HPLC) for flavonoids and the related compounds (m-HPAA, p-HPAA and DOPAC) were validated, determining the parameters of accuracy, precision, specificity or selectivity, limit of detection, quantification range, and robustness. The pharmacokinetic assay was performed with ICR mice strains, which were given 200 mg/kg of the standardized active fraction. The results of validation of the analytical methods were obtained, allowing it to be established in a validated way that no flavonoids present in the anxiolytic fraction of T. americana were detected in plasma. However, detection and follow up was possible for the serum levels of m-HPAA, p-HPAA, and DOPAC. The three compounds follow a two-compartment model with very similar parameters between m-HPAA and p-HPAA, some being different from the ones characterized in the pharmacokinetics of DOPAC. View Full-Text
Keywords: Tilia americana; anxiolytic; pharmacokinetic Tilia americana; anxiolytic; pharmacokinetic
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Juárez Ramírez, V.A.; Jiménez-Beltrán, M.I.; Zamilpa, A.; Herrera-Ruiz, M.; Abarca-Vargas, R.; Lombardo-Earl, G.; Tortoriello, J.; Jiménez-Ferrer, E. Pharmacokinetic Study of Biotransformation Products from an Anxiolytic Fraction of Tilia americana. Molecules 2017, 22, 1260.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top